002210 — Dongsung Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapSucker Stock

Market Cap
KR₩91bn
Enterprise Value
KR₩140bn
Revenue
KR₩88bn

Annual balance sheet for Dongsung Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,362	5,143	4,094	6,435	3,145
Net Total Accounts Receivable
Net Total Receivables	26,561	27,903	33,083	31,291	35,995
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71,507	49,986	54,389	60,815	68,152
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37,313	37,378	43,960	42,725	73,450
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	125,718	104,582	107,702	114,973	151,913
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	43,273	37,589	47,571	44,844	77,033
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	70,770	58,141	64,893	75,171	96,734
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	54,948	46,440	42,809	39,802	55,178
Total Liabilities & Shareholders' Equity	125,718	104,582	107,702	114,973	151,913
Total Common Shares Outstanding